Overview

Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis

Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of SLIT compared with placebo for reduction of symptoms and rescue medication usage
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Stallergenes
Stallergenes Greer
Treatments:
Immunologic Factors